PHASE Scientific Raises US$34 Million Series A Round to Advance Urine-Based Diagnostic Technology for Early Disease Detection

PHASE Scientific International Limited completed a US$34 million Series A funding round, the largest in Asia's diagnostic technology sector since 2019, to accelerate R&D and commercialization of its proprietary PHASIFY™ urine-based diagnostic technology for early detection of cancers, women's health issues, and infectious diseases.